Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Falling Comet
172.5800 0.13 (0.08%)
NSE Jan 16, 2026 15:31 PM
Volume: 472.5K
 

172.58
0.08%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
FII/FPI have decreased holdings from 16.92% to 8.13% in Dec 2025 qtr
More from Marksans Pharma Ltd.
Recommended